Contineum Therapeutics, Inc. CTNM
9.72 USD +0.03 (+0.31%)
Nov 4, 2026, 3:30 PM EST
9.56 Day range 10.32
6.73 52-week range 17.79
- YTD
- -14.96%
- 1 year
- -6.45%
Financial health
Altman Z-Score
15.48 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
Valuation
P/E -5.3×
FY 2021 5y median -9.0× FY 2025
P/S 0.0×
FY 2021 5y median 0.0× FY 2025
P/B 1.2×
FY 2021 5y median 1.9× FY 2025
P/FCF -5.7×
FY 2021 5y median -11.4× FY 2025
EV/EBITDA -3.7×
FY 2021 5y median -8.6× FY 2025
EV/Sales 0.0×
FY 2021 5y median 0.0× FY 2025
FCF Yield -17.5%
FY 2021 5y median -6.8% FY 2025
Profitability
Gross Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2021 5y median 0.0% FY 2025
ROE -23.0%
FY 2021 5y median -33.4% FY 2025
ROIC -25.3%
FY 2021 5y median -25.3% FY 2025
ROA -21.7%
FY 2021 5y median -21.7% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2021 FY 2025
Operating Income -33.7%
FY 2021 FY 2025
EPS (diluted) -33.1%
FY 2021 FY 2025
Free Cash Flow -66.5%
FY 2021 FY 2025
Financial Health
Current Ratio 27.5×
FY 2021 5y median 20.7× FY 2025
Quick Ratio 27.5×
FY 2021 5y median 20.7× FY 2025
Debt / Equity 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 1.0×
FY 2021 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2021 5y median -58.6× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31